BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16911313)

  • 1. Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis.
    Zeitler H; Ulrich-Merzenich G; Hoffmann L; Kornblum C; Schmidt S; Vetter H; Walger P
    Artif Organs; 2006 Aug; 30(8):597-605. PubMed ID: 16911313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of myasthenia gravis with immunoadsorption.
    Haas M; Mayr N; Zeitlhofer J; Goldammer A; Derfler K
    J Clin Apher; 2002; 17(2):84-7. PubMed ID: 12210711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
    Köhler W; Bucka C; Klingel R
    J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment with 7S immunoglobulins in myasthenia gravis. Preliminary clinical results].
    Bamberg C; Janzen RW; Szabados M
    Nervenarzt; 1996 Apr; 67(4):327-32. PubMed ID: 8684513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The modified Bonn Malmö protocol (MBMP) in the treatment of acquired haemophilia A].
    Zeitler H; Ulrich-Merzenich G; Walger P; Düsing R; Vetter H; Brackmann HH
    Dtsch Med Wochenschr; 2006 Jan; 131(4):141-7. PubMed ID: 16429335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
    Heigl F; Hettich R; Arendt R; Durner J; Koehler J; Mauch E
    Atheroscler Suppl; 2013 Jan; 14(1):167-73. PubMed ID: 23357160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorption in patients with autoimmune ion channel disorders of the peripheral nervous system.
    Antozzi C
    Atheroscler Suppl; 2013 Jan; 14(1):219-22. PubMed ID: 23357168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myasthenia gravis].
    Tanaka K
    Nihon Rinsho; 2004 May; 62 Suppl 5():580-5. PubMed ID: 15197988
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive respiratory care in patients with myasthenic crisis.
    Aggarwal AN; Gupta D; Behera D; Prabhakar S; Jindal SK
    Neurol India; 2002 Sep; 50(3):348-51. PubMed ID: 12391468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenic crisis: a retrospective study.
    Panda S; Goyal V; Behari M; Singh S; Srivastava T
    Neurol India; 2004 Dec; 52(4):453-6. PubMed ID: 15626832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy.
    Psaridi-Linardaki L; Trakas N; Mamalaki A; Tzartos SJ
    J Neuroimmunol; 2005 Feb; 159(1-2):183-91. PubMed ID: 15652418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive ventilation in myasthenic crisis.
    Seneviratne J; Mandrekar J; Wijdicks EF; Rabinstein AA
    Arch Neurol; 2008 Jan; 65(1):54-8. PubMed ID: 18195139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of tacrolimus on myasthenia gravis with thymoma.
    Mitsui T; Kunishige M; Ichimiya M; Shichijo K; Endo I; Matsumoto T
    Neurologist; 2007 Mar; 13(2):83-6. PubMed ID: 17351528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients.
    Baggi F; Ubiali F; Nava S; Nessi V; Andreetta F; Rigamonti A; Maggi L; Mantegazza R; Antozzi C
    J Neuroimmunol; 2008 Sep; 201-202():104-10. PubMed ID: 18644634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of combined immunosuppressive treatment on myasthenic crisis.
    Rózsa C; Mikor A; Kasa K; Illes Z; Komoly S
    Eur J Neurol; 2009 Jul; 16(7):796-800. PubMed ID: 19453406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of selected hematologic parameters during long-term immunoadsorption therapy.
    Pták J
    Transfus Apher Sci; 2005 Nov; 33(3):299-304. PubMed ID: 16203175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)].
    Lavrnić DB; Stojanović V; Marinković Z; Pavlović S; Vidaković A; Apostolski S
    Srp Arh Celok Lek; 1995; 123(5-6):146-8. PubMed ID: 17974459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term outcome of patients with acquired haemophilia--a monocentre interim analysis of 82 patients.
    Zeitler H; Goldmann G; Marquardt N; Ulrich-Merzenich G
    Atheroscler Suppl; 2013 Jan; 14(1):223-8. PubMed ID: 23357169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.